Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$40.5M |
| 2 |
S&P Global
SPGI
|
+$30.2M |
| 3 |
Medtronic
MDT
|
+$25.3M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$23.2M |
| 5 |
Northrop Grumman
NOC
|
+$20.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$63.7M |
| 2 |
Conagra Brands
CAG
|
+$20.3M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$20M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$18.2M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$15.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 13.74% |
| 2 | Healthcare | 12.91% |
| 3 | Technology | 11.18% |
| 4 | Consumer Discretionary | 11.04% |
| 5 | Industrials | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
Cinemark Holdings
CNK
$4.8B
| $737K | 0.03% |
19,210
+4,451
| +30% | +$177K |
2016 Q3
1 quarter
|
|
627
Mettler-Toledo International
MTD
$34.4B
| $737K | 0.03% |
+1,761
| New | +$733K |
2016 Q4
0 quarters
|
|
628
iShares MSCI Singapore ETF
EWS
$1.04B
| $735K | 0.03% |
36,894
+26,533
| +256% | +$555K |
2016 Q3
1 quarter
|
|
629
Pinnacle West Capital
PNW
$13B
| $733K | 0.03% |
9,389
-3,963
| -30% | -$297K |
2016 Q3
1 quarter
|
|
630
Chimera Investment
CIM
$555M
| $727K | 0.03% |
+14,233
| New | +$697K |
2016 Q4
0 quarters
|
|
|
TCF
631
DELISTED
TCF Financial Corporation
TCF
| $726K | 0.03% |
+37,063
| New | +$611K |
2016 Q4
0 quarters
|
|
632
DELISTED
Exact Sciences
EXAS
| $725K | 0.03% |
+54,294
| New | +$877K |
2016 Q4
0 quarters
|
|
|
WMGI
633
DELISTED
Wright Medical Group Inc
WMGI
| $725K | 0.03% |
31,534
+21,695
| +221% | +$505K |
2016 Q3
1 quarter
|
|
634
Hancock Whitney
HWC
$5.17B
| $724K | 0.03% |
16,795
+2,993
| +22% | +$114K |
2016 Q1
3 quarters
|
|
635
SBA Communications
SBAC
$19.5B
| $724K | 0.03% |
7,013
+613
| +10% | +$64.5K |
2016 Q3
1 quarter
|
|
636
MFA Financial
MFA
$562M
| $722K | 0.03% |
+23,650
| New | +$710K |
2016 Q4
0 quarters
|
|
637
Teradyne
TER
$41.2B
| $722K | 0.03% |
+28,408
| New | +$674K |
2016 Q4
0 quarters
|
|
|
GNC
638
DELISTED
GNC Holdings, Inc.
GNC
| $720K | 0.03% |
+65,200
| New | +$1.02M |
2016 Q4
0 quarters
|
|
639
iShares MSCI Hong Kong ETF
EWH
$1.3B
| $717K | 0.03% |
+36,786
| New | +$772K |
2016 Q4
0 quarters
|
|
|
ACOR
640
DELISTED
Acorda Therapeutics
ACOR
| $717K | 0.03% |
+318
| New | +$756K |
2016 Q4
0 quarters
|
|
641
Sturm, Ruger & Co
RGR
$790M
| $716K | 0.03% |
13,583
+6,602
| +95% | +$365K |
2016 Q1
3 quarters
|
|
|
FPRX
642
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $716K | 0.03% |
+14,282
| New | +$750K |
2016 Q4
0 quarters
|
|
643
Pathward Financial
CASH
$1.56B
| $715K | 0.03% |
+20,832
| New | +$582K |
2016 Q4
0 quarters
|
|
644
iShares MSCI United Kingdom ETF
EWU
$3.73B
| $714K | 0.03% |
+23,265
| New | +$708K |
2016 Q4
0 quarters
|
|
645
Packaging Corp of America
PKG
$22.3B
| $714K | 0.03% |
8,417
-4,786
| -36% | -$401K |
2016 Q2
2 quarters
|
|
646
Sempra
SRE
$51.7B
| $712K | 0.03% |
+14,156
| New | +$721K |
2016 Q4
0 quarters
|
|
647
Genworth Financial
GNW
$3.08B
| $711K | 0.03% |
186,722
+54,529
| +41% | +$240K |
2016 Q3
1 quarter
|
|
648
SAP
SAP
$270B
| $710K | 0.03% |
8,214
-7,203
| -47% | -$619K |
2016 Q3
1 quarter
|
|
649
Toro Company
TTC
$10.1B
| $710K | 0.03% |
12,686
+8,168
| +181% | +$417K |
2016 Q3
1 quarter
|
|
|
FCB
650
DELISTED
FCB Financial Holdings, Inc.
FCB
| $708K | 0.03% |
+14,839
| New | +$614K |
2016 Q4
0 quarters
|
|
Similar funds
Squarepoint's Q4 2016 Portfolio in Review
As of Q4 2016, Squarepoint held 2,060 positions worth $2.44B, up 62% from $1.51B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Squarepoint deployed $913M of net new capital in Q4 2016, opening 1,079 new positions and adding to 424 existing holdings. Its largest new stake was S&P Global: 252,484 shares worth $27.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 14% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Conagra Brands, an estimated $20.3M trimmed.
- Squarepoint's largest Q4 2016 buy was S&P Global: 252,484 shares worth $27.2M.
- Squarepoint added most to iShares China Large-Cap ETF in Q4 2016, an estimated $40.5M increase.
- Squarepoint's biggest Q4 2016 reduction was Conagra Brands, cutting an estimated $20.3M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q4 2016, selling an estimated $63.7M.
- Squarepoint's ten largest holdings make up 9.6% of its $2.44B portfolio in Q4 2016.
- Squarepoint opened 1,079 new positions and closed 329 in Q4 2016.
- Squarepoint's portfolio value rose 62% quarter-over-quarter to $2.44B.
Based on Squarepoint's 13F filing for Q4 2016, filed 14 Feb 2017.